Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iFIT (UK-MRA Myeloma XVIII): Immunotherapy Approaches Adapted for Fitness in Newly Diagnosed Transplant Ineligible Patients With Myeloma

NCT07649525 is registered in ClinicalTrials.gov with University of Leeds as lead sponsor.

NCT NCT07649525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07649525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iFIT (UK-MRA Myeloma XVIII): Immunotherapy Approaches Adapted for Fitness in Newly Diagnosed Transplant Ineligible Patients With Myeloma
Lead sponsor
University of Leeds
Phase
Phase 3
Overall status
Recruiting
Start date
July 31, 2026
Completion date
June 30, 2037
Enrollment
1,226 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma (mm), plasma cell leukemia (pcl)